Methylphenidate Hydrochloride
NDC 62175-312, Methylphenidate Hydrochloride, tablet, extended release, from Lannett Company, Inc..
- Product NDC
- 62175-312
- Status
- Listed
- Labeler
- Lannett Company, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA091695
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/62175-312 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHYLPHENIDATE HYDROCHLORIDE36 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62175-312-37 | 62175031237 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-312-37) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3d1f5aff-5d39-496c-b5ed-7f3c70ec641cNADAC price for package 62175031237
GET /v1/drugs/nadac/62175031237
Use it
Look up 62175-312 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62175-312 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62175-312. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.